Valeant Pharmaceuticals Annonces New $1.5 Billion Securites Repurchase ...

News | 19 November 2012

MONTREAL, Nov. 19, 2012 -- /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) announced today that its board of directors has authorized a new securities repurchase program (the "Securities Repurchase Program").

Click on the link to read the full article at Sacramento Bee
(This link will open in a new window)